Dirithromycin

In the US, Dirithromycin (dirithromycin systemic) is a member of the drug class macrolides and is used to treat Bronchitis, Legionella Pneumonia, Mycoplasma Pneumonia, Otitis Media, Pneumonia, Skin Infection, Tonsillitis/Pharyngitis and Upper Respiratory Tract Infection.

US matches:

• Dirithromycin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01FA13

CAS registry number (Chemical Abstracts Service)

0062013-04-1

Chemical Formula

C42-H78-N2-O14

Molecular Weight

835

Therapeutic Category

Antibacterial: Macrolide

Chemical Name

(9S)-9-Deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)ethylidene]oxy]erythromycin

Foreign Names

• Dirithromycinum (Latin)
• Dirithromycin (German)
• Dirithromycine (French)
• Dirithromycina (Spanish)

Generic Names

• Dirithromycin (OS: BAN, USAN)
• Dirithromycine (OS: DCF)
• AS-E 136 BS (IS)
• LY 237216 (IS)
• Dirithromycin (PH: BP 2010, USP 32, Ph. Eur. 6)
• Dirithromycine (PH: Ph. Eur. 6)
• Dirithromycinum (PH: Ph. Eur. 6)

Brand Names

• Dynabac
  Abdi Ibrahim, Turkey



• Unibac
  Lilly, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.